Job Listings


Here are our current job openings. Please click on the job title for more information, and apply from that page if you are interested.

Use this form to perform another job search

The system cannot access your location for 1 of 2 reasons:
  1. Permission to access your location has been denied. Please reload the page and allow the browser to access your location information.
  2. Your location information has yet to be received. Please wait a moment then hit [Search] again.


Jounce Therapeutics, Inc. is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients. Through the use of our Translational Science Platform, we first focus on specific cell types within tumors to prioritize targets, and then identify related biomarkers designed to match the right therapy to the right patient. Jounce was launched in 2013 with funding from leading life sciences investor, Third Rock Ventures. In July 2016, Jounce announced a global strategic collaboration with Celgene Corporation. This global strategic collaboration, which included a $225.0 million upfront payment and a $36.1 million equity investment, is primarily focused on co developing and co commercializing innovative biologic immunotherapy treatments for patients with cancer.

Jounce is an equal employment opportunity employer and does not discriminate against any applicant because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, disability, genetic information, veteran status, military status, application for military service or any other class protected by state or federal law.

All applicants should be legally entitled to work for any employer in the U.S.

Note to Employment Agencies: Please do not forward any agency resumes. The company will not be responsible for any fees related to resumes that are unsolicited.
Click column header to sort

Search Results

Jounce Therapeutics, Inc. is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long‑lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right therapy to the right patient. Jounce’s lead product candidate, JTX-2011, is a monoclonal antibody that binds to and activates ICOS and is currently in a Phase 1/2 trial. For more information, please visit http://jouncetx.com/ We have many career opportunities at Jounce and are looking for exceptional individuals who share our passion and perseverance for developing highly durable cancer immunotherapies that can dramatically impact and improve patients’ lives.
Job ID
2018-1130
Location
US-MA-Cambridge
Jounce Therapeutics, Inc. is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long‑lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right therapy to the right patient. Jounce’s lead product candidate, JTX-2011, is a monoclonal antibody that binds to and activates ICOS and is currently in a Phase 1/2 trial. For more information, please visit http://jouncetx.com/   We have many career opportunities at Jounce and are looking for exceptional individuals who share our passion and perseverance for developing highly durable cancer immunotherapies that can dramatically impact and improve patients’ lives.
Job ID
2018-1129
Location
US-MA-Cambridge
The Clinical Trial Manager (CTM) will work collaboratively with the Lead Clinical Trial Manager to drive ongoing clinical studies.  The CTM will also independently organize and manage multiple activities related to clinical studies, while simultaneously ensuring study milestones are met and studies are completed in accordance with the protocol.  Future growth opportunities would include independently managing  small studies of basic to moderate complexity or defined activities in more complex, multicenter studies (e.g., managing vendors).
Job ID
2018-1128
Location
US-MA-Cambridge
We are seeking a scientific informatics professional with flexibility and breadth of experience who is interested in working with Jounce's Research organization to address data management challenges, improve scientific data integration, manage software licensing, and progress therapeutic drug development.   This is an exciting opportunity to join the IT and Informatics professionals in a growing immunotherapy company.  As a member of the Research Informatics team, the candidate will work under the supervision of the manager of Research Informatics to help drive scientific informatics projects from inception through training and support in order to serve the needs of Research and Development.
Job ID
2018-1127
Location
US-MA-Cambridge
The Vice President of Clinical Development will oversee all global Clinical programs at Jounce. As the Clinical Development Lead, you will play a key leadership role as Jounce evolves as a clinical stage biotech company. This role will actively participate in and supervise the clinical development team in the design and execution of the clinical development strategy for JTX-2011 (ICOS agonist in Phase 2), JTX-4014 (PD-1 inhibitor with IND in 2018), the lead macrophage program (in IND enabling studies), and provide clinical leadership to discovery teams on other programs as they advance towards and enter the clinic. This is a high impact, highly influential role that reports directly to Jounce’s Chief Medical Officer.
Job ID
2018-1126
Location
US-MA-Cambridge
Jounce Therapeutics, Inc. (JNCE) is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long‑lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right therapy to the right patient. Jounce’s lead product candidate, JTX-2011, is a monoclonal antibody that binds to and activates ICOS and is currently in a Phase 1/2 trial. For more information, please visit http://jouncetx.com/.
Job ID
2018-1125
Location
US-MA-Cambridge
Jounce Therapeutics is an immuno-oncology company dedicated to transforming the treatment of cancer. The company is discovering and developing novel cancer immunotherapies designed to harness the immune system to attack tumors and provide long-lasting benefits to patients. Jounce integrates translational science insights including identification of related biomarkers designed to match the right immunotherapy to the right patients. The company is advancing programs that leverage contributions from its world-class founders as well as knowledge acquired from Jounce’s Translational Science Platform to create a sustainable “discovery to human proof-of-concept” product engine with the potential to drive significantly more durable responses to treatment. Founded by world leaders in tumor immunology, cancer biology and clinical and translational medicine, Jounce Therapeutics was launched in 2013 with funding from leading life sciences investor, Third Rock Ventures.
Job ID
2018-1124
Location
US-MA-Cambridge
The successful candidate will assist with daily clinical trial execution activities and assist in the coordination of documentation associated with the conduct of investigational clinical studies in accordance with Food and Drug Administration (FDA) Regulations, Good Clinical Practice (GCP), and company standard operating policies and procedures.
Job ID
2018-1123
Location
US-MA-Cambridge
The IT and Informatics group at Jounce Therapeutics is looking for an experienced IT End User Services manager to join the Jounce IT team. The individual will manage end user services activities such as: Employee onboarding, helpdesk services, mobile device management, video conference services, application training and management. The individual will report to the Manager of Information Technology. The person in this position will help drive success and resolution to the customers’ needs as they oversee the Jounce help desk team. This individual will partner with counterparts in IT as well as throughout the company to ensure alignment of applicable end user technologies and services and focus on delivering a high level of internal customer service/satisfaction. This is a challenging position in the dynamic field of immuno-oncology which provides opportunity for growth in a fast-paced, start-up like environment.
Job ID
2018-1122
Location
US-MA-Cambridge
The Protein production group at Jounce Therapeutics is looking for an individual experienced in molecular biology, mammalian cell culture, protein purification, and characterization.  The successful candidate will play an important role in the discovery and development of novel biotherapeutics for immuno-oncology.  He/she will be will be responsible for the production of antibodies and proteins for use in R&D that will enable the development of groundbreaking therapies.  He/she will be expected to participate in experimental design, conduct experiments, optimize throughput, maintain detailed records, and generate standard operating procedures.  This is an exciting opportunity to be part of a fast-paced environment in the dynamic field of immuno-oncology.
Job ID
2017-1119
Location
US-MA-Cambridge
This role will guide efforts in the generation of biologic leads derived from discovery and optimization platforms for the development of novel therapeutics. In this position you will manage a team of scientists in support of therapeutic programs focused in immuno-oncology. This role requires direct expertise in antibody generation from immunogen selection through selection of best platform to enable creation of a broad panel of potential antibody candidates, antibody screening methodologies, and the engineering and optimization of lead candidates.  In addition, the preferred candidate will also have knowledge of biologic topologies, platform technologies, and developability assessment for lead candidate selection.
Job ID
2017-1117
Location
US-MA-Cambridge